Shanghai Hanyu Medical Technology Co., Ltd., established in 2016, specializes in the research, development, production, and sales of interventional devices for structural heart disease and electrophysiology in human medicine.

The company has developed a strong foundation in core technologies, including: Design and manufacturing of precision adjustable deflectable catheters; Development and processing of novel cardiac occluders; Design and fabrication of mitral valve clipping devices; Engineering and production of transcatheter valve structures; Design and application control of pulsed field ablation (PFA) catheter electrodes; Processing and manufacturing of superelastic materials; Advanced precision machining for implantable cardiovascular devices.

With its expertise and commitment to innovation, Shanghai Hanyu Medical continues to drive advancements in the field of cardiovascular intervention.

Established in 2019, Shanghai Hongyu Medical Technology Co., Ltd. is a global leader in veterinary cardiology, focusing on the diagnosis and treatment of heart diseases in pets. With its core product, the V-Clamp for minimally invasive mitral valve disease treatment in dogs, Hongyu Medical is expanding into diagnostics, treatment, and monitoring for various cardiac conditions, offering a comprehensive solution for pet heart disease. In addition to developing, manufacturing, and selling veterinary cardiac devices, Hongyu Medical promotes collaboration and knowledge-sharing among veterinarians worldwide by providing training on heart disease diagnosis, treatment, and care for animals.

Founded in 2019, Shanghai Xinyu Animal (Cardiac Specialty) Hospital is a flagship cardiac specialty hospital under Shanghai Hongyu Medical. As the first veterinary heart hospital in China to perform minimally invasive mitral valve surgery, Xinyu provides specialized cardiac treatments and advanced services for pets nationwide. The hospital also offers training and technical support for global veterinary hospitals and medical centers, drawing on a skilled veterinary and post-care team and state-of-the-art medical equipment. Services include minimally invasive mitral valve regurgitation surgery and hands-on device training for domestic and international experts. By the end of 2024, Xinyu had provided V-Clamp technology training to over 70 hospitals worldwide.

Shanghai Quanxin Medical Technology Co., Ltd. was established in 2022 and is headquartered in Minhang District, Shanghai. As a medical technology company specializing in the cardiovascular health industry, Quanxin Medical has accumulated deep expertise and holds a leading technological position in the field of valve replacement. The company is committed to providing safe, efficient, and comprehensive valve replacement solutions for heart disease patients.